Endovascular Treatment in Acute Ischemic Stroke Adoption and Practice: A Single-Center Indonesian Experience

Cerebrovasc Dis Extra. 2021;11(2):72-76. doi: 10.1159/000517183. Epub 2021 Jul 20.

Abstract

Indonesia is facing increasing stroke prevalence in the past 5 years. Ischemic stroke imposes economic and productivity burden if it is not addressed properly. Endovascular treatment studies are conducted in developed countries where facilities and cost do not count in therapy consideration if it is indicated. Developing countries like Indonesia should work hard to provide the best hyperacute stroke care with protocol deviation and limitation. This is the first review on endovascular treatment practice in a top single-center hospital in Indonesia. Further improvement is needed to catch up with state-of-the-art hyperacute ischemic stroke treatment.

Keywords: Acute ischemic stroke; Developing countries; Endovascular treatment; Indonesia; Intravenous thrombolysis.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Developing Countries*
  • Endovascular Procedures* / adverse effects
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Indonesia / epidemiology
  • Infusions, Intravenous
  • Ischemic Stroke / diagnosis
  • Ischemic Stroke / epidemiology
  • Ischemic Stroke / therapy*
  • Male
  • Middle Aged
  • Prevalence
  • Retrospective Studies
  • Thrombectomy* / adverse effects
  • Thrombolytic Therapy* / adverse effects
  • Time Factors
  • Treatment Outcome

Substances

  • Fibrinolytic Agents